Evaluation of the Visual Acuity Curves of an Enhanced Monofocal Intraocular Lens (NCT07439835) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of the Visual Acuity Curves of an Enhanced Monofocal Intraocular Lens
Greece62 participantsStarted 2024-04-01
Plain-language summary
The primary objective of this study is to evaluate postoperative visual acuity curves in pseudophakic patients following unilateral or bilateral implantation of the enhanced monofocal TECNIS Eyhance IOL, using the DDARTVC.
Who can participate
Age range
45 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* age between 45 to 75 years
Exclusion Criteria:
* astigmatism \>1.00 diopters
* glaucoma
* former incisional eye surgery
* corneal or fundus disease
* diabetes mellitus
* autoimmune diseases
* neurological or psychiatric diseases
* posterior capsule rupture or lens misalignment
* postoperative uncorrected distance visual acuity \< 8/10.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial tested an 'enhanced monofocal' intraocular lens — how is that different from a standard monofocal lens I might otherwise receive for my cataract, and what range of vision distances would it realistically cover?
2Since this trial has already been completed, has my doctor seen the results, and do they suggest this type of lens performed better than traditional options for uncorrected vision at different distances?
3The trial measured 'vision-related quality of life' as an outcome — based on those findings, what real-world activities like reading or driving can I expect to do comfortably without glasses after this type of lens is implanted?
4How does the 'area of the visual acuity curve' that was measured in this study translate into what I would actually notice day-to-day compared to a standard lens?
5Given that this trial is completed but not yet a standard of care recommendation, would my doctor consider this enhanced monofocal lens a proven enough option for my situation, or might a conventional lens or a different premium lens be a safer or better-studied choice for me?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.